Cargando…
Plasma Levels of Apelinergic System Components in Patients with Chronic and Acute Coronary Syndromes—A Pilot Study
The effects of the apelinergic system components apelin (AP) and elabela (ELA) in the regulation of human cardiovascular homeostasis, and data concerning the relationship between ELA and AP and coronary artery disease (CAD) are yet unknown. The aim of the study was the evaluation of AP, ELA and APJ-...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509670/ https://www.ncbi.nlm.nih.gov/pubmed/34640437 http://dx.doi.org/10.3390/jcm10194420 |
_version_ | 1784582398404460544 |
---|---|
author | Diakowska, Dorota Wyderka, Rafal Krzystek-Korpacka, Małgorzata Osuch, Łukasz Leśków, Anna Sołtowska, Alicja Stanek, Marta Rosińczuk, Joanna Jaroch, Joanna |
author_facet | Diakowska, Dorota Wyderka, Rafal Krzystek-Korpacka, Małgorzata Osuch, Łukasz Leśków, Anna Sołtowska, Alicja Stanek, Marta Rosińczuk, Joanna Jaroch, Joanna |
author_sort | Diakowska, Dorota |
collection | PubMed |
description | The effects of the apelinergic system components apelin (AP) and elabela (ELA) in the regulation of human cardiovascular homeostasis, and data concerning the relationship between ELA and AP and coronary artery disease (CAD) are yet unknown. The aim of the study was the evaluation of AP, ELA and APJ-receptor levels in the plasma of patients with chronic coronary syndromes (CCS) and acute coronary syndromes (ACS). The study group consisted of 114 patients with CAD and 33 healthy controls. Patients were divided into two groups: with CCS (n = 30) and ACS (n = 84). Routine laboratory tests and plasma ELA, AP-17, AP-13 and APJ receptor levels were measured. Echocardiographic data were analyzed in all patients. Levels of AP-17 and ELA were significantly lower in CCS than in healthy controls and ACS patients. We demonstrated significant increase of levels of plasma apelinergic system peptides, especially ELA and AP-17 in ACS patients compared with healthy controls and CCS, suggestive of compensating up-regulation mechanisms. There is a relationship between circulating ELA and AP-17 levels and classical, biochemical markers of ischemia and left ventricular ejection faction as well. |
format | Online Article Text |
id | pubmed-8509670 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-85096702021-10-13 Plasma Levels of Apelinergic System Components in Patients with Chronic and Acute Coronary Syndromes—A Pilot Study Diakowska, Dorota Wyderka, Rafal Krzystek-Korpacka, Małgorzata Osuch, Łukasz Leśków, Anna Sołtowska, Alicja Stanek, Marta Rosińczuk, Joanna Jaroch, Joanna J Clin Med Article The effects of the apelinergic system components apelin (AP) and elabela (ELA) in the regulation of human cardiovascular homeostasis, and data concerning the relationship between ELA and AP and coronary artery disease (CAD) are yet unknown. The aim of the study was the evaluation of AP, ELA and APJ-receptor levels in the plasma of patients with chronic coronary syndromes (CCS) and acute coronary syndromes (ACS). The study group consisted of 114 patients with CAD and 33 healthy controls. Patients were divided into two groups: with CCS (n = 30) and ACS (n = 84). Routine laboratory tests and plasma ELA, AP-17, AP-13 and APJ receptor levels were measured. Echocardiographic data were analyzed in all patients. Levels of AP-17 and ELA were significantly lower in CCS than in healthy controls and ACS patients. We demonstrated significant increase of levels of plasma apelinergic system peptides, especially ELA and AP-17 in ACS patients compared with healthy controls and CCS, suggestive of compensating up-regulation mechanisms. There is a relationship between circulating ELA and AP-17 levels and classical, biochemical markers of ischemia and left ventricular ejection faction as well. MDPI 2021-09-26 /pmc/articles/PMC8509670/ /pubmed/34640437 http://dx.doi.org/10.3390/jcm10194420 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Diakowska, Dorota Wyderka, Rafal Krzystek-Korpacka, Małgorzata Osuch, Łukasz Leśków, Anna Sołtowska, Alicja Stanek, Marta Rosińczuk, Joanna Jaroch, Joanna Plasma Levels of Apelinergic System Components in Patients with Chronic and Acute Coronary Syndromes—A Pilot Study |
title | Plasma Levels of Apelinergic System Components in Patients with Chronic and Acute Coronary Syndromes—A Pilot Study |
title_full | Plasma Levels of Apelinergic System Components in Patients with Chronic and Acute Coronary Syndromes—A Pilot Study |
title_fullStr | Plasma Levels of Apelinergic System Components in Patients with Chronic and Acute Coronary Syndromes—A Pilot Study |
title_full_unstemmed | Plasma Levels of Apelinergic System Components in Patients with Chronic and Acute Coronary Syndromes—A Pilot Study |
title_short | Plasma Levels of Apelinergic System Components in Patients with Chronic and Acute Coronary Syndromes—A Pilot Study |
title_sort | plasma levels of apelinergic system components in patients with chronic and acute coronary syndromes—a pilot study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509670/ https://www.ncbi.nlm.nih.gov/pubmed/34640437 http://dx.doi.org/10.3390/jcm10194420 |
work_keys_str_mv | AT diakowskadorota plasmalevelsofapelinergicsystemcomponentsinpatientswithchronicandacutecoronarysyndromesapilotstudy AT wyderkarafal plasmalevelsofapelinergicsystemcomponentsinpatientswithchronicandacutecoronarysyndromesapilotstudy AT krzystekkorpackamałgorzata plasmalevelsofapelinergicsystemcomponentsinpatientswithchronicandacutecoronarysyndromesapilotstudy AT osuchłukasz plasmalevelsofapelinergicsystemcomponentsinpatientswithchronicandacutecoronarysyndromesapilotstudy AT leskowanna plasmalevelsofapelinergicsystemcomponentsinpatientswithchronicandacutecoronarysyndromesapilotstudy AT sołtowskaalicja plasmalevelsofapelinergicsystemcomponentsinpatientswithchronicandacutecoronarysyndromesapilotstudy AT stanekmarta plasmalevelsofapelinergicsystemcomponentsinpatientswithchronicandacutecoronarysyndromesapilotstudy AT rosinczukjoanna plasmalevelsofapelinergicsystemcomponentsinpatientswithchronicandacutecoronarysyndromesapilotstudy AT jarochjoanna plasmalevelsofapelinergicsystemcomponentsinpatientswithchronicandacutecoronarysyndromesapilotstudy |